Jørgen Bardenfleth

Deputy chairman, member of the Board of Directors since 2018

Education: MSc in Engineering from the Technical University of Denmark (DTU) and a MBA from the University of California, Los Angeles.

Background: Professional board member since 2013, prior General Manager in high tech companies Microsoft, Intel and Hewlett-Packard 1989-2013. Board and steering committee work in Danish Science Parks, Innovationsfonden and Innovation Technology consortias.

Other ongoing assignments: Chairman Impero A/S, Bizbrains A/S, Dubex A/S and Symbion A/S, Vice Chairman at BLOXHUB, Board member at CN3 A/S, BIM Genetics ApS, Accelerace, Jumpstory ApS, Vallø Stift, Copenhagen Capacity.

Independence: Independent in relation to both the Company and executive management.

Scandion Oncology shares and warrants
457.629 shares and 96.407 warrants (partly owned via Lioneagle ApS).